The principal scientific journal for the profession in New Zealand

Issue Vol 133 No 1519: 31 July 2020

New Zealand’s  ‘Cannabis Legalisation and Regulation Bill’: an evidence-based assessment and  critique of essential regulatory components towards policy outcomes

ARTICLE
Vol 133 No 1519: 31 July 2020

Challenges for the future: the gastroenterology specialist workforce in New Zealand

New Zealand’s healthcare system is funded by government garnered taxes and offers a comprehensive set of free core health services to all New Zealanders as well as those who live in New Zealand and hold a residency or work visa.

ARTICLE
Vol 133 No 1519: 31 July 2020

Preventing acute kidney injury: assessing awareness to temporarily discontinue ‘at-risk’ medicines during acute illness in a New Zealand cohort

Acute kidney injury (AKI) is an increasingly common clinical problem affecting kidney structure and function, and is defined as an abrupt onset of renal dysfunction ranging from minor loss of function to organ failure.

ARTICLE
Vol 133 No 1519: 31 July 2020

Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand | OPEN ACCESS

New Zealand’s first case of coronavirus disease 2019 (COVID-19) due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was confirmed on 28 February 2020 at Auckland City Hospital in an adult who had recently travelled overseas.

ARTICLE
Vol 133 No 1519: 31 July 2020

An understanding of discordant SARS-CoV-2 test results: an examination of the data from a central Auckland laboratory | OPEN ACCESS

SARS-CoV-2 is the causative agent of Coronavirus Disease 2019 (COVID-19). The SARS-CoV-2 pandemic has infected over seven million people worldwide (data accessed on 8 June), with 1,504 cases in New Zealand.

ARTICLE
Vol 133 No 1519: 31 July 2020

Chronic hepatitis B infection—an unmet medical need in New Zealand 35 years after universal neonatal vaccination

Chronic hepatitis B virus (HBV) infection is a recognised global health priority and in 2016 the World Health Organisation (WHO) adopted the first-ever global hepatitis strategy to eliminate viral hepatitis as a public health threat by 2030.

ARTICLE
Vol 133 No 1519: 31 July 2020

Appropriateness of trimethoprim as empiric treatment for cystitis in 15–55 year-old women: an audit

Cystitis is a common presentation in primary care. Uncomplicated cystitis is defined as occurring in females with a normal urinary tract.

ARTICLE
Vol 133 No 1519: 31 July 2020

Hip abductor tendon tears—a survey of New Zealand orthopaedic surgeons

Hip abductor tendon tears are a common cause of greater trochanteric pain syndrome, affecting up to 20% of those over the age of 50.

ARTICLE
Vol 133 No 1519: 31 July 2020

Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39)

Atrial fibrillation (AF), the most commonly encountered clinical arrhythmia, often coexists with acute coronary syndrome (ACS).

ARTICLE
Vol 133 No 1519: 31 July 2020

Falls risk factor assessment and secondary prevention in the older old

Falls are common in older adults with half of community-dwelling people aged 80 years and over experiencing a fall in one year.

ARTICLE
Vol 133 No 1518: 17 July 2020

VOICES: South Island pilot survey of bereaved people

From 2016–2038, the number of people dying in New Zealand is predicted to increase by almost 50%. These projections indicate that palliative care requirements will increase by 37.5% in public hospitals, 84.2% in aged residential care (ARC) and 51.8% in hospice care.